Evidence map›Paper›PMID 42664234›Full record

ArticlePLOS digital health2026

ITHindex: An integrated web-based platform for intratumor heterogeneity evaluation.

Yutao Liu, Yuan Jiang, Wenchuan Xie, Feidie Duan, Shuiting Fu, Jing Zhao, Jinyu Yang, Jianchun Duan, Guoqiang Wang, Yuzi Zhang and 2 more

Abstract read
In one paragraph

Article in PLOS digital health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Yutao LiuDepartment of Medical Oncology, State Key Laboratory of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Yuan JiangThe Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University/Hunan Cancer Hospital, Changsha, Hunan, China.
Wenchuan XieBurning Rock Biotech, Guangzhou, Guangdong, China.
Feidie DuanBurning Rock Biotech, Guangzhou, Guangdong, China.
Shuiting FuDepartment of Oral and Maxillofacial-Head Neck Oncology, Department of Laser and Aesthetic Medicine, Shanghai Ninth People's Hospital, College of Stomatology, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Jing ZhaoBurning Rock Biotech, Guangzhou, Guangdong, China.
Jinyu YangBurning Rock Biotech, Guangzhou, Guangdong, China.
Jianchun DuanDepartment of Medical Oncology, State Key Laboratory of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Guoqiang WangBurning Rock Biotech, Guangzhou, Guangdong, China.
Yuzi ZhangBurning Rock Biotech, Guangzhou, Guangdong, China.
Shangli CaiBurning Rock Biotech, Guangzhou, Guangdong, China.
Yongqin WenDepartment of Pathology, Shenzhen University of Advanced Technology General Hospital, Shenzhen, Guangdong, China.ORCID https://orcid.org/0009-0009-8093-3436

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Intratumor heterogeneity (ITH) is a critical factor influencing cancer progression, therapeutic response, and the development of drug resistance. Despite its importance, the lack of a definitive gold standard for ITH quantification has hindered consistent clinical application. To bridge this gap, we developed ITHindex, a web-based, research-enabling platform that integrates a pragmatic subset of 17 user-accessible ITH algorithms within the R Shiny framework. The tool supports diverse data modalities, including somatic mutation, copy number variation, transcriptomic, proteomic, and methylation profiles. By analyzing 11,242 samples across 32 cancer types from The Cancer Genome Atlas (TCGA) and 4,904 samples from cBioPortal, alongside 398 paired tissue and plasma samples, we validated the platform's utility in quantifying ITH and characterizing the relationships between diverse metrics. ITHindex streamlines the computational pipeline, providing researchers with a robust tool for systematic ITH investigation and data-driven biomarker discovery. The ITHindex server is freely accessible at https://shinyapps.brbiotech.com/app/ithindex.

Identifiers

PMID42664234
PMCPMC13524247

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.